Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Travere Therapeutics
TVTX
$5.89B
| $1.07M | ﹤0.01% |
75,097
+45,744
| +156% | +$584K |
|
|
RODI
3577
DELISTED
iPath Return on Disability ETN
RODI
| $1.06M | ﹤0.01% |
12,000
-488,000
| -98% | -$41.5M |
|
|
FTSV
3578
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $1.06M | ﹤0.01% |
27,046
+10,337
| +62% | +$166K |
|
3579
AngioDynamics
ANGO
$625M
| $1.06M | ﹤0.01% |
66,410
+20,930
| +46% | +$320K |
|
3580
iShares Global Tech ETF
IXN
$8.74B
| $1.06M | ﹤0.01% |
30,300
| – | – |
|
3581
Nelnet
NNI
$4.85B
| $1.06M | ﹤0.01% |
18,241
-6,228
| -25% | -$381K |
|
3582
Amphastar Pharmaceuticals
AMPH
$873M
| $1.06M | ﹤0.01% |
54,961
+17,564
| +47% | +$337K |
|
|
KEM
3583
CALL
DELISTED
KEMET Corporation
KEM
| $1.06M | ﹤0.01% |
39,200
-15,500
| -28% | -$376K |
|
3584
RE/MAX Holdings
RMAX
$230M
| $1.06M | ﹤0.01% |
27,432
+7,389
| +37% | +$265K |
|
3585
Cars.com
CARS
$656M
| $1.06M | ﹤0.01% |
86,398
-90,870
| -51% | -$1.06M |
|
|
AERI
3586
DELISTED
Aerie Pharmaceuticals
AERI
| $1.05M | ﹤0.01% |
43,648
+13,298
| +44% | +$275K |
|
3587
HealthStream
HSTM
$822M
| $1.05M | ﹤0.01% |
38,788
+10,996
| +40% | +$302K |
|
3588
Tronox
TROX
$1.11B
| $1.05M | ﹤0.01% |
92,285
+27,523
| +42% | +$275K |
|
3589
Blue Bird Corp
BLBD
$2.09B
| $1.05M | ﹤0.01% |
45,949
+38,330
| +503% | +$766K |
|
3590
CALL
Transocean
RIG
$5.71B
| $1.05M | ﹤0.01% |
152,500
-367,700
| -71% | -$1.89M |
|
3591
CALL
Cencora
COR
$63.2B
| $1.05M | ﹤0.01% |
12,300
-1,300
| -10% | -$111K |
|
3592
PUT
Royal Bank of Canada
RY
$294B
| $1.04M | ﹤0.01% |
13,200
+8,700
| +193% | +$701K |
|
|
AEGN
3593
DELISTED
Aegion Corp
AEGN
| $1.04M | ﹤0.01% |
46,656
+12,634
| +37% | +$273K |
|
3594
PUT
STMicroelectronics
STM
$47.5B
| $1.04M | ﹤0.01% |
38,700
-74,300
| -66% | -$1.76M |
|
3595
V2X
VVX
$2.65B
| $1.04M | ﹤0.01% |
20,311
+1,972
| +11% | +$95.1K |
|
3596
Univest Financial
UVSP
$1.21B
| $1.04M | ﹤0.01% |
38,842
+24,207
| +165% | +$626K |
|
|
AVLR
3597
DELISTED
Avalara, Inc.
AVLR
| $1.04M | ﹤0.01% |
14,166
-137,680
| -91% | -$10M |
|
|
AVX
3598
DELISTED
AVX Corporation
AVX
| $1.04M | ﹤0.01% |
50,755
+9,902
| +24% | +$171K |
|
|
SLCA
3599
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.04M | ﹤0.01% |
168,445
-3,062
| -2% | -$18.5K |
|
3600
PUT
ProShares UltraShort Bloomberg Crude Oil
SCO
$726M
| $1.03M | ﹤0.01% |
1,063
-171
| -14% | -$199K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.